{A figure is presented}Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience

Salma Akram, Joseph A Murray, Darrell S. Pardi, Glenn L. Alexander, John A. Schaffner, Pierre A. Russo, Susan C. Abraham

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Background & Aims: Autoimmune enteropathy is a rare cause of intractable diarrhea associated with circulating gut autoantibodies and a predisposition to autoimmunity. It is rarely observed in adults, with only 11 cases reported to date. Methods: Fifteen adults with autoimmune enteropathy were identified at the Mayo Clinic, Rochester, from May 2001-June 2006. The demographic, clinical, and treatment data were abstracted from their records. Results: The study population was 87% white, 47% female, with median age of 55 years (interquartile range, 42-67 years). All patients had protracted diarrhea, weight loss, and malnutrition. Celiac disease was excluded by lack of response to gluten-free diet or absence of the celiac disease susceptibility HLA genotypes. Fourteen patients were tested for gut epithelial cell antibodies, and 93% were positive for anti-enterocyte and/or anti-goblet cell antibodies. Predisposition to autoimmune diseases was noted in 80%, as indicated by a variety of circulating autoantibodies. Small intestinal histopathologic findings included subtotal villous atrophy and lymphoplasmacytic infiltration in the lamina propria with relatively few surface intraepithelial lymphocytes. T-cell receptor gene rearrangement studies were negative in all cases. Immunosuppressive therapy was required in 93% of cases. Clinical improvement was noted in 60% after 1-8 weeks of steroid therapy. Conclusions: Autoimmune enteropathy is a heterogeneous disease and should be considered in the differential diagnosis of malabsorption and small bowel villous atrophy. The presence of gut epithelial cell antibodies can help confirm the diagnosis. No single agent is unequivocally effective in inducing remission, and immunosuppressive therapy is required in most cases.

Original languageEnglish (US)
Pages (from-to)1282-1290
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume5
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Celiac Disease
Immunosuppressive Agents
Autoantibodies
Atrophy
Antibodies
Diarrhea
Epithelial Cells
T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
Gluten-Free Diet
Goblet Cells
Enterocytes
Disease Susceptibility
Therapeutics
Autoimmunity
Malnutrition
Autoimmune Diseases
Weight Loss
Mucous Membrane
Differential Diagnosis

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Akram, S., Murray, J. A., Pardi, D. S., Alexander, G. L., Schaffner, J. A., Russo, P. A., & Abraham, S. C. (2007). {A figure is presented}Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience. Clinical Gastroenterology and Hepatology, 5(11), 1282-1290. https://doi.org/10.1016/j.cgh.2007.05.013

{A figure is presented}Adult Autoimmune Enteropathy : Mayo Clinic Rochester Experience. / Akram, Salma; Murray, Joseph A; Pardi, Darrell S.; Alexander, Glenn L.; Schaffner, John A.; Russo, Pierre A.; Abraham, Susan C.

In: Clinical Gastroenterology and Hepatology, Vol. 5, No. 11, 11.2007, p. 1282-1290.

Research output: Contribution to journalArticle

Akram, Salma ; Murray, Joseph A ; Pardi, Darrell S. ; Alexander, Glenn L. ; Schaffner, John A. ; Russo, Pierre A. ; Abraham, Susan C. / {A figure is presented}Adult Autoimmune Enteropathy : Mayo Clinic Rochester Experience. In: Clinical Gastroenterology and Hepatology. 2007 ; Vol. 5, No. 11. pp. 1282-1290.
@article{dd6066745ccc4a76821ec7e7eb60c574,
title = "{A figure is presented}Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience",
abstract = "Background & Aims: Autoimmune enteropathy is a rare cause of intractable diarrhea associated with circulating gut autoantibodies and a predisposition to autoimmunity. It is rarely observed in adults, with only 11 cases reported to date. Methods: Fifteen adults with autoimmune enteropathy were identified at the Mayo Clinic, Rochester, from May 2001-June 2006. The demographic, clinical, and treatment data were abstracted from their records. Results: The study population was 87{\%} white, 47{\%} female, with median age of 55 years (interquartile range, 42-67 years). All patients had protracted diarrhea, weight loss, and malnutrition. Celiac disease was excluded by lack of response to gluten-free diet or absence of the celiac disease susceptibility HLA genotypes. Fourteen patients were tested for gut epithelial cell antibodies, and 93{\%} were positive for anti-enterocyte and/or anti-goblet cell antibodies. Predisposition to autoimmune diseases was noted in 80{\%}, as indicated by a variety of circulating autoantibodies. Small intestinal histopathologic findings included subtotal villous atrophy and lymphoplasmacytic infiltration in the lamina propria with relatively few surface intraepithelial lymphocytes. T-cell receptor gene rearrangement studies were negative in all cases. Immunosuppressive therapy was required in 93{\%} of cases. Clinical improvement was noted in 60{\%} after 1-8 weeks of steroid therapy. Conclusions: Autoimmune enteropathy is a heterogeneous disease and should be considered in the differential diagnosis of malabsorption and small bowel villous atrophy. The presence of gut epithelial cell antibodies can help confirm the diagnosis. No single agent is unequivocally effective in inducing remission, and immunosuppressive therapy is required in most cases.",
author = "Salma Akram and Murray, {Joseph A} and Pardi, {Darrell S.} and Alexander, {Glenn L.} and Schaffner, {John A.} and Russo, {Pierre A.} and Abraham, {Susan C.}",
year = "2007",
month = "11",
doi = "10.1016/j.cgh.2007.05.013",
language = "English (US)",
volume = "5",
pages = "1282--1290",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - {A figure is presented}Adult Autoimmune Enteropathy

T2 - Mayo Clinic Rochester Experience

AU - Akram, Salma

AU - Murray, Joseph A

AU - Pardi, Darrell S.

AU - Alexander, Glenn L.

AU - Schaffner, John A.

AU - Russo, Pierre A.

AU - Abraham, Susan C.

PY - 2007/11

Y1 - 2007/11

N2 - Background & Aims: Autoimmune enteropathy is a rare cause of intractable diarrhea associated with circulating gut autoantibodies and a predisposition to autoimmunity. It is rarely observed in adults, with only 11 cases reported to date. Methods: Fifteen adults with autoimmune enteropathy were identified at the Mayo Clinic, Rochester, from May 2001-June 2006. The demographic, clinical, and treatment data were abstracted from their records. Results: The study population was 87% white, 47% female, with median age of 55 years (interquartile range, 42-67 years). All patients had protracted diarrhea, weight loss, and malnutrition. Celiac disease was excluded by lack of response to gluten-free diet or absence of the celiac disease susceptibility HLA genotypes. Fourteen patients were tested for gut epithelial cell antibodies, and 93% were positive for anti-enterocyte and/or anti-goblet cell antibodies. Predisposition to autoimmune diseases was noted in 80%, as indicated by a variety of circulating autoantibodies. Small intestinal histopathologic findings included subtotal villous atrophy and lymphoplasmacytic infiltration in the lamina propria with relatively few surface intraepithelial lymphocytes. T-cell receptor gene rearrangement studies were negative in all cases. Immunosuppressive therapy was required in 93% of cases. Clinical improvement was noted in 60% after 1-8 weeks of steroid therapy. Conclusions: Autoimmune enteropathy is a heterogeneous disease and should be considered in the differential diagnosis of malabsorption and small bowel villous atrophy. The presence of gut epithelial cell antibodies can help confirm the diagnosis. No single agent is unequivocally effective in inducing remission, and immunosuppressive therapy is required in most cases.

AB - Background & Aims: Autoimmune enteropathy is a rare cause of intractable diarrhea associated with circulating gut autoantibodies and a predisposition to autoimmunity. It is rarely observed in adults, with only 11 cases reported to date. Methods: Fifteen adults with autoimmune enteropathy were identified at the Mayo Clinic, Rochester, from May 2001-June 2006. The demographic, clinical, and treatment data were abstracted from their records. Results: The study population was 87% white, 47% female, with median age of 55 years (interquartile range, 42-67 years). All patients had protracted diarrhea, weight loss, and malnutrition. Celiac disease was excluded by lack of response to gluten-free diet or absence of the celiac disease susceptibility HLA genotypes. Fourteen patients were tested for gut epithelial cell antibodies, and 93% were positive for anti-enterocyte and/or anti-goblet cell antibodies. Predisposition to autoimmune diseases was noted in 80%, as indicated by a variety of circulating autoantibodies. Small intestinal histopathologic findings included subtotal villous atrophy and lymphoplasmacytic infiltration in the lamina propria with relatively few surface intraepithelial lymphocytes. T-cell receptor gene rearrangement studies were negative in all cases. Immunosuppressive therapy was required in 93% of cases. Clinical improvement was noted in 60% after 1-8 weeks of steroid therapy. Conclusions: Autoimmune enteropathy is a heterogeneous disease and should be considered in the differential diagnosis of malabsorption and small bowel villous atrophy. The presence of gut epithelial cell antibodies can help confirm the diagnosis. No single agent is unequivocally effective in inducing remission, and immunosuppressive therapy is required in most cases.

UR - http://www.scopus.com/inward/record.url?scp=35548937748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548937748&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2007.05.013

DO - 10.1016/j.cgh.2007.05.013

M3 - Article

C2 - 17683994

AN - SCOPUS:35548937748

VL - 5

SP - 1282

EP - 1290

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11

ER -